Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2003 | 2004 | 2005 | 2006 | 2007 | |
|---|---|---|---|---|---|
| Revenue | $3.5K | $2.4M | $2.5M | $2.4M | $3.2M |
| Cost of revenue | $3.8K | $282.6K | $302.2K | $217.5K | $362.7K |
| Gross profit | −$301 | $2.1M | $2.2M | $2.2M | $2.9M |
| Gross margin | -8.6% | 88.0% | 87.9% | 91.1% | 88.8% |
| R&D | $0 | $0 | $85.9K | $1.1K | $196.0K |
| Operating income | $52.3K | $992.1K | $920.6K | $846.7K | $466.1K |
| EBITDA | −$48.9K | $1.1M | $980.4K | $902.6K | $789.7K |
| Net income | −$52.3K | $1.0M | $625.0K | $619.0K | $342.5K |
| Net margin | -1500.3% | 43.1% | 25.1% | 25.4% | 10.6% |
| EPS (diluted) | -0.01 | 0.06 | 0.04 | 0.03 | 0.02 |
Annual figures · source: Financial Modeling Prep
GENEX PHARMACEUTICAL INC
No one on the platform currently holds GENX.
No tracked institution reports a position in GENX as of their last filing.
| Execution date | Ratio |
|---|---|
| 2004-07-01 | 4-for-1 |
No one on the platform has traded GENX yet.
| $1641 |
| — |
| LTHOLegacy Technology Holdings, Inc. | $0.00 | +0.00% | $1720 | — |
| MRRCFWayland Group Corp. | $0.00 | +0.00% | $2121 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.